| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 6.3% stake in AMENDED FILING ARCTURUS THERAPEUTICS HOLDINGS INC |
| 10/04/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $25.6123, valued at
$128.1k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/26/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 08/17/2023 |
4
| SASSINE ANDY (CFO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 1,223 shares
@ $17.374, valued at
$21.2k
|
|
| 08/14/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results |
| 08/07/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/03/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $34.91, valued at
$174.6k
|
|
| 08/03/2023 |
4
| Markels John (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| Marantz Jing L. (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| HOLMES EDWARD W (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| BARLOW JAMES F (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/18/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 25,000 shares
@ $35.01, valued at
$875.3k
|
|
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 07/07/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $28.75, valued at
$143.8k
|
|
| 06/30/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 06/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/28/2023 |
8-K
| Quarterly results |
| 04/21/2023 |
8-K
| Quarterly results |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|